Breast Cancer: A Complete Guide to Types, Stages, and Treatment
Breast cancer is the most commonly diagnosed cancer in women worldwide, affecting approximately 1 in 8 women in the United States over their lifetime. With advances in early detection and treatment, survival rates have improved dramatically — the 5-year relative survival rate for localized breast cancer is now 99%.
Written by
Dr. Sarah Chen, MD
Preventive Medicine
Medically reviewed by
Dr. Amelia Richardson, MD
Board-Certified Oncologist
Key Takeaways
- 1 in 8 women will be diagnosed with breast cancer in their lifetime — early detection is critical
- Annual mammograms beginning at age 40 are recommended for average-risk women
- BRCA1/BRCA2 gene mutations significantly increase risk — genetic testing may be recommended for high-risk individuals
- 5-year survival rate for localized breast cancer is 99% when detected early
- Limiting alcohol and maintaining a healthy weight are the most impactful modifiable risk reduction strategies
In This Article
Understanding Breast Cancer
Breast cancer occurs when cells in the breast grow uncontrollably, forming a tumor that can be felt as a lump or detected on an imaging scan. Most breast cancers begin in the ducts (ductal carcinoma) that carry milk to the nipple, while others start in the lobules (lobular carcinoma) that produce milk. A cancer is considered invasive when it has spread from its point of origin into surrounding breast tissue. The most common type is invasive ductal carcinoma (IDC), accounting for approximately 70–80% of all breast cancer diagnoses. Understanding the specific type of breast cancer is essential because it directly determines treatment approach and prognosis.
Risk Factors and Prevention
Several factors increase the risk of developing breast cancer. Non-modifiable risk factors include being female (though men can get breast cancer), increasing age, family history, inherited genetic mutations (particularly BRCA1 and BRCA2), dense breast tissue, and prior radiation to the chest. Modifiable risk factors that you can actively address include alcohol consumption (each additional drink per day increases risk by 7–10%), physical inactivity, postmenopausal obesity, hormone therapy use after menopause, and having a first full-term pregnancy after age 30. While no approach guarantees prevention, research shows that regular exercise, maintaining a healthy weight, limiting alcohol, and breastfeeding if possible can meaningfully reduce risk.
Screening and Early Detection
Screening mammography is the most important tool for early breast cancer detection. Annual mammograms beginning at age 40 are recommended by the American Cancer Society for average-risk women, with discussions about starting at 40 or 45 based on individual risk. Women with significantly elevated risk due to BRCA mutations or strong family history should discuss supplemental screening with MRI beginning at 30. Clinical breast exams and breast self-awareness (knowing how your breasts normally look and feel) are additional detection methods. Three-dimensional mammography (tomosynthesis) has improved detection rates, particularly in women with dense breast tissue. When detected at stage I, breast cancer has a 5-year survival rate of approximately 99%, making early detection life-saving.
Staging and Treatment Overview
Breast cancer staging (0 through IV) describes how far the cancer has spread and guides treatment decisions. Stage 0 (DCIS) is non-invasive and typically treated with surgery and radiation. Stages I–III involve local and regional spread and are generally treated with combinations of surgery, radiation, chemotherapy, hormone therapy, and targeted therapy. Stage IV (metastatic) has spread to distant organs; treatment focuses on controlling disease and maintaining quality of life. Targeted therapies have transformed outcomes for HER2-positive breast cancers, with drugs like trastuzumab (Herceptin) dramatically improving survival. For hormone receptor-positive cancers, endocrine therapies like tamoxifen and aromatase inhibitors are highly effective. Immunotherapy is an emerging option for triple-negative breast cancer.
Life After Breast Cancer
The vast majority of early-stage breast cancer patients go on to live long, full lives after treatment. Survivorship care focuses on monitoring for recurrence, managing long-term treatment side effects, and supporting overall health. Follow-up appointments typically include physical exams every 3–6 months for the first 3 years, then annually. Lymphedema (arm swelling due to lymph node removal) is a potential long-term side effect that can be managed with specialized physical therapy. Emotional well-being is equally important: research shows that depression and anxiety are common after a breast cancer diagnosis, and psychological support significantly improves quality of life. Support groups, individual therapy, and mind-body practices like yoga and mindfulness all have evidence supporting their benefit during and after treatment.
